2m 2m 2m 2m 2m 2m 2m
XTL BIOPHARM SP ADR (XTLB)
NASDAQ
$2.71-$0.17 (-5.87%)
Price as of Jul 13, 2026 6:28 PM EDT- $7.2MMarket Cap
- -55.83%1-Year Change
- BiotechnologyIndustry
XTL BIOPHARM SP ADR (XTLB)
$2.71-$0.17 (-5.87%)
XTLB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.88 | ||
Change | -$0.03 (-1.03%) | ||
Open | $2.89 | ||
High | $2.90 | ||
Low | $2.69 | ||
Previous Close | $2.91 | ||
Volume | 5,576 | ||
30-Day Average Volume | 213,488 | ||
1-Week Change | -8.28% | ||
1-Month Change | 35.21% | ||
1-Year Change | -55.83% | ||
3-Year Change | -22.99% | ||
5-Year Change | -79.43% | ||
Fundamentals | |||
Shares Outstanding | 2.5M | ||
Total Assets | $166,000.00 | ||
Market Cap | $7.2M | ||
Enterprise Value | $7.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 4 | ||
Last Split Date | 03/25/2026 | ||
Earnings & Revenue